stars 1 stars 2 stars 3

ImmuneWorks is a clinical stage biotechnology company with deep expertise in immunology and lung disease. The Company, based in Indianapolis, was founded in 2006, receiving an exclusive license from Indiana University. ImmuneWorks is developing IW001, using an immune modulation approach to treat idiopathic pulmonary fibrosis ("IPF"), an orphan disease indication with significant unmet medical need. ImmuneWorks has completed a Phase 1 trial in IPF patients, which demonstrated safety and evidence of clinical efficacy via oral administration of IW001.

ImmuneWorks, Inc. Questions

The ImmuneWorks, Inc. annual revenue was $3 million in 2026.

ImmuneWorks, Inc. is based in Indianapolis, Indiana.

The NAICS codes for ImmuneWorks, Inc. are [325, 32, 32541, 3254].

The SIC codes for ImmuneWorks, Inc. are [28, 283].

Learn More
How It Works
get free account
Get a Free Account
Sign up for a free account. No credit card required. Up to 5 free lookups.
search page
Search the #1 Contact Database
Get contact details of over 700M profiles across 60M companies – all with industry-leading accuracy. Sales and Recruiter users, try out our Email Finder Extension.
get contact page
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.
G2 Leader Winter 2026 G2 Leader Mid Market Winter 2026 G2 Leader Small Business Winter 2026 G2 Most Implementable Winter 2026 G2 Best Est ROI Mid Market Winter 2026 G2 Leader Momentum Winter 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2025
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users